utilizes its proprietary instrument control software and
well proven mechanical systems for rapid development of
synthesis platforms ranging from analytical to
preparative scale systems. The rapid growth of oligonucleotide
based drug design is creating the need for Very Large Scale instrumentation capable of
performing unique and nonstandard monomer additions. The products and
technology developed by Genomic Technologies help scientists accelerate the
discovery of new therapeutic drugs and diagnostic
requirements for larger and more unique oligomers develop, our proprietary design
platforms for rapid synthesis, combined with our
chemistry expertise and software capabilities enabled our
customers to quickly access and manage synthesis
information. We provide "leading edge" tools
required for biotechnology development.
holds patents and trademarks, and licenses its
technology which includes high throughput oligonucleotide
oligonucleotide sequence database management software, web-based
order processing software, diagnostic and therapeutic scale oligonucleotide synthesizers,
and high throughput multi-instrument control software.
Technologies is a privately held company
located in Millis, Massachusetts.
The company focuses
on the development of products and technologies which enable the scientific community to rapidly sequence genomes and develop
the knowledge gained, toward therapeutic and diagnostic products.
Technologies manufactures several standardized hardware and software
products and markets these products to DNA synthesis houses and genome sequencing facilities world-wide. In addition, the company is
collaborating with engineering firms, custom synthesis facilities and pharmaceutical
companies to develop specialized instrumentation and software systems which provide
unique capabilities to the end user.
Genomic - See Contact Link to the Right